KENDRA TRUE: Open Payments
NPI 1790394294 · BELOIT, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$168 in 9 payments from 7 companies in 2025. Trend: 2023 $229 · 2024 $203 · 2025 $168
Food & beverage: $168
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $56 |
| Dexcom, Inc. | 1 | $22 |
| E.R. Squibb & Sons, L.L.C. | 1 | $20 |
| Amgen Inc. | 1 | $19 |
| Novartis Pharmaceuticals Corporation | 1 | $18 |
| Seqirus USA Inc | 1 | $18 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $14 |
Products named: VRAYLAR, Dexcom G6 Transmitter, CAMZYOS, OTEZLA, LEQVIO, Fluad, TEFLARO, JARDIANCE.
Industry payments across KS — which companies pay providers there.
